Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Helius Medical Technologies ( (HSDT) ).
On July 21, 2025, Helius Medical Technologies announced the successful results of their PoNS Stroke Registrational Program, which began in March 2024. The program’s clinical trials demonstrated significant improvements in gait and balance deficits in stroke patients, with minimal adverse events, supporting an upcoming FDA submission for a new indication under the Breakthrough Device Designation. The trials involved 159 patients and were conducted across 10 clinical sites in the US and Canada, highlighting the potential impact on stroke rehabilitation and the company’s market positioning.
The most recent analyst rating on (HSDT) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on Helius Medical Technologies stock, see the HSDT Stock Forecast page.
Spark’s Take on HSDT Stock
According to Spark, TipRanks’ AI Analyst, HSDT is a Neutral.
Helius Medical Technologies’ overall stock score is heavily impacted by its poor financial performance and technical analysis, both scoring at the lower end due to negative earnings, declining revenue, and bearish technical indicators. While the company has recently improved its compliance status with Nasdaq, financial and technical weaknesses dominate the stock’s overall performance.
To see Spark’s full report on HSDT stock, click here.
More about Helius Medical Technologies
Helius Medical Technologies, Inc. operates in the medical technology industry, focusing on the development of non-invasive platform technologies for the treatment of neurological symptoms caused by disease or trauma. Their primary product is the Portable Neuromodulation Stimulator (PoNS) device, which is aimed at improving gait and balance deficits in patients with chronic neurological conditions.
Average Trading Volume: 152,808
Technical Sentiment Signal: Strong Sell
Current Market Cap: $6.02M
Learn more about HSDT stock on TipRanks’ Stock Analysis page.